Live Breaking News & Updates on Mcdonnell boehnen hulbert

Stay informed with the latest breaking news from Mcdonnell boehnen hulbert on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Mcdonnell boehnen hulbert and stay connected to the pulse of your community

Biomedical Device Consultants and Laboratories of Colorado, LLC v. Vivitro Labs, Inc. (Fed. Cir. 2024) | McDonnell Boehnen Hulbert & Berghoff LLP

A preliminary injunction is one of the most potent weapons in a patent plaintiff's arsenal, being capable of shutting down an accused infringer's continued infringement, prohibiting the...

China , Colorado , United-states , Chinese , Laboratories-of-colorado , Novo-nordisk , Vivitro-labs-inc , Council-inc , Mcdonnell-boehnen-hulbert-berghoff , Disrtrict-court , Genentech-inc

Edwards Lifesciences Corp. v. Meril Life Sciences Pvt. (Fed. Cir. 2024) | McDonnell Boehnen Hulbert & Berghoff LLP

A fractured affirmance of a district court decision to dismiss an infringement action under 35 U.S.C. § 271(e)(1) was the occasion for the Federal Circuit to illustrate the continued...

India , United-states , Teva-pharm , Bolar-pharm , Supreme-court , Waxman-act-in-edwards-lifesciences-corp , Exitron-corp , Roche-prods-inc , United-states-inc , Integra-lifesciencesi-ltd , Amgen , Meril-life-sciences-pvt

USPTO Updates Service Methods for Notices of Appeal and Related Documents | McDonnell Boehnen Hulbert & Berghoff LLP

In a Federal Register notice dated March 29, 2024, the U.S. Patent and Trademark Office is updating the required method for serving it with a notice of appeal to the U.S. Court of...

Trademark-office , Us-court , Office-of-the-solicitor , Mcdonnell-boehnen-hulbert-berghoff , Mcdonnell-boehnen-hulbert , Federal-register , Federal-circuit , Priority-mail , General-counsel , Post-office ,

Cardiovalve Ltd. v. Edwards Lifesciences Corp. (Fed. Cir. 2024) | McDonnell Boehnen Hulbert & Berghoff LLP

Last week, the Federal Circuit handed down a pair of non-precedential decisions affirming the Patent Trial and Appeal Board (PTAB) in inter partes review (IPR) proceedings. This post...

Giles-rich , Bayer-schering-pharma , Mcdonnell-boehnen-hulbert-berghoff , Barr-laboratories-inc , Uber-technologies-inc , Teleflex-inc , Cardiovalve-ltd , Supreme-court , X-one-inc , International-co , Edwards-lifesciences-corp , Mcdonnell-boehnen-hulbert

Medtronic, Inc. v. Teleflex Life Sciences Ltd. (Fed. Cir. 2024) | McDonnell Boehnen Hulbert & Berghoff LLP

Last week the Federal Circuit handed down a pair of non-precedential decisions affirming the Patent Trial and Appeal Board (PTAB) in inter partes review (IPR) proceedings. This post...

Baldwin-graphic-sys-inc , Siebert-inc , Teleflex-life-sciences-ltd , Medtronic , Netflix-inc , Mformation-techs-inc , Lan-inc , C-inc , Apple-inc , Motion-ltd , Teleflex-inc

The New York Times Response to Microsoft's Motion to Dismiss: An LLM Is Not a VCR | McDonnell Boehnen Hulbert & Berghoff LLP

As discussed in our earlier post, Microsoft opened its motion to dismiss portions of the New York Times's OpenAI case pled against it with an extended analogy to the Betamax case. It...

Boston , Massachusetts , United-states , New-york , America , American , Jack-valenti , Arts-inc , Napster-inc , New-york-times , Motion-picture-association-of-america , Microsoft

Pfizer Inc. v. Sanofi Pasteur Inc. (Fed. Cir. 2024) | McDonnell Boehnen Hulbert & Berghoff LLP

Last week, the Federal Circuit handed down its opinion in Pfizer Inc. v. Sanofi Pasteur Inc., affirming the Patent Trial and Appeal Board's (PTAB) determination that all claims of U.S....

New-zealand , United-states , Office-guidance , Genentech-inc , Pfizer , Apotex-inc , Pfizer-inc , Challengers-merck-sharp-dohme-corp , Sanofi-pasteur-inc , Arthrex-inc , Ei-dupont-de-nemours-co

FDA Approves Three Interchangeable Biosimilar Drugs in 2024 | McDonnell Boehnen Hulbert & Berghoff LLP

After taking most of a decade to approve its first interchangeable biosimilar (Semglee (insulin glargine-yfgn), the U.S. Food and Drug Administration has approved three interchangeable...

Amgen , Mcdonnell-boehnen-hulbert-berghoff , Teva-pharmaceuticals , Drug-administration , Mcdonnell-boehnen-hulbert ,

AI News Roundup – OpenAI launches Sora, Nvidia stock price increases, universal AI model for biology and more | McDonnell Boehnen Hulbert & Berghoff LLP

There’s a lot happening in the world of AI. To help you stay on top of the latest news, we have compiled a roundup of the developments we are following. OpenAI recently announced...

France , California , United-states , Hollywood , French , Tyler-perry , Google-deepmind , Jensen-huang , Sarah-silverman , Nehisi-coates , Araceli-martinez-olguin , Mcdonnell-boehnen-hulbert-berghoff

The New York Times Case against OpenAI is Different. Here's Why. | McDonnell Boehnen Hulbert & Berghoff LLP

On December 27, 2023, The New York Times Company ("The Times") sued several OpenAI entities and their stakeholder Microsoft ("OpenAI") in the Southern District of New York for copyright...

New-york , United-states , Mona-awad , Julian-sancton , Sarah-silverman , Michael-chabon , Paul-tremblay , York-times-company , Us-copyright-office , Author-guild , New-york-times , Mcdonnell-boehnen-hulbert-berghoff